Location History:
- West Lafayette, IN (US) (2014 - 2015)
- Silver Spring, MD (US) (2015)
Company Filing History:
3 out of 2,660 
1 out of 3,539 
Years Active: 2014-2015
Title: Evgeny A Kiselev: Innovator in Pharmaceutical Chemistry
Introduction
Evgeny A Kiselev is a notable inventor based in West Lafayette, IN (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds for cancer treatment. With a total of 3 patents, Kiselev's work has the potential to impact medical therapies significantly.
Latest Patents
Kiselev's latest patents include innovative compounds and their applications. One of his notable inventions is related to substituted dibenzonaphthyridines, which are pharmaceutical compositions aimed at treating and preventing cancer. This invention encompasses the synthesis of dibenzonaphthyridine compounds and their formulations. Another significant patent involves azaindenoisoquinoline topoisomerase I inhibitors. This invention focuses on substituted azaindenoisoquinoline compounds that inhibit topoisomerase I, along with their synthesis processes and pharmaceutical compositions for cancer treatment.
Career Highlights
Throughout his career, Kiselev has worked with reputable organizations, including the Purdue Research Foundation and the United States Department of Health and Human Services. His work in these institutions has allowed him to advance his research and contribute to the development of important pharmaceutical innovations.
Collaborations
Kiselev has collaborated with esteemed colleagues such as Mark Stanley Cushman and Andrew E Morrell. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical compounds.
Conclusion
Evgeny A Kiselev's contributions to pharmaceutical chemistry through his innovative patents demonstrate his commitment to advancing cancer treatment. His work continues to inspire future research in the field.